ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12074 recruiting trials
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Aug 2024View details ↗
Danish Vulva Cancer Recurrence Study
👨⚕️ Pernille T. Jensen, Professor, Aarhus University Hospital📍 2 sites📅 Started Aug 2024View details ↗
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
RecruitingNCT06561399 ↗
Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
👨⚕️ Somedeb Ball, MD, Vanderbilt University/Ingram Cancer Center📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06547099 ↗
Study to Understand Novel Biomarkers in Researching Dementia
👨⚕️ Randall Bateman, MD, Washington University School of Medicine📍 1 site📅 Started Aug 2024View details ↗
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
👨⚕️ Nikolaos Trikalinos, Yale University Cancer Center LAO📍 10 sites📅 Started Aug 2024View details ↗
Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC
👨⚕️ Jinghui Wang, Director of Research Laboratory, Beijing Chest Hospital📍 1 site📅 Started Aug 2024View details ↗
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
RecruitingNCT06861530 ↗
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
👨⚕️ Lin Shen, Peking University Cancer Hospital & Institute📍 1 site📅 Started Aug 2024View details ↗
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
👨⚕️ Michiel S. van der Heijden, PhD, The Netherlands Cancer Institute📍 2 sites📅 Started Aug 2024View details ↗
MSC EVs in Dystrophic Epidermolysis Bullosa
👨⚕️ David T Woodley, MD, University of Southern California Dept of Dermatology📍 3 sites📅 Started Aug 2024View details ↗
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
👨⚕️ Hui Wei, MD, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Aug 2024View details ↗
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →